Article
25-hydroxyvitamin D sufficiency is associated with lower de novo anti-HLA donor specific antibody and better kidney transplant outcomes.
HLA - 1 Jan 2024
Bakis Hugo, Bouthemy Charlène, Corcuff Jean-Benoît, Lauro Cindy, Guidicelli Gwendaline, Cargou Marine, Guibet Claire, Taton Benjamin, Merville Pierre, Couzi Lionel, Moreau Karine, Visentin Jonathan
Abstract excerpt
T-cell mediated rejection (TCMR), de novo anti-HLA donor-specific antibodies (dnDSAs) and ensuing antibody-mediated rejection (ABMR) reduce kidney transplantation (KT) survival. The immunomodulatory effects of 25-hydroxyvitamin D [25(OH)D] could be beneficial for KT outcomes. We aimed to evaluating the association between 25(OH)D levels, the development of dnDSAs, clinical TCMR and ABMR, and graft survival. This...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
